Old Web
English
Sign In
Acemap
>
authorDetail
>
Adriana Ladungova
Adriana Ladungova
Central European Institute of Technology
Biology
CD19
Cancer research
Chimeric antigen receptor
Chronic lymphocytic leukemia
3
Papers
12
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro
2021
Journal for ImmunoTherapy of Cancer
Aneta Ledererová
Lenka Dostalova
Veronika Kozlová
Helena Peschelova
Adriana Ladungova
Martin Čulen
Tomáš Loja
Jan Verner
Šárka Pospíšilová
Michal Šmída
Veronika Mančíková
Show All
Source
Cite
Save
Citations (1)
Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia.
2020
Journal for ImmunoTherapy of Cancer
Veronika Mančíková
Helena Peschelova
Veronika Kozlová
Aneta Ledererová
Adriana Ladungova
Jan Verner
Tomáš Loja
František Folber
Jiri Mayer
Šárka Pospíšilová
Michal Šmída
Show All
Source
Cite
Save
Citations (4)
CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells.
2020
PLOS ONE
Veronika Kozlová
Aneta Ledererová
Adriana Ladungova
Helena Peschelova
Pavlína Janovská
Aleksander Ślusarczyk
Joanna Domagala
Pavel Kopcil
Viera Vakulová
Jan Oppelt
Vítězslav Bryja
Michael Doubek
Jiri Mayer
Šárka Pospíšilová
Michal Šmída
Show All
Source
Cite
Save
Citations (7)
1
map